… utilizing bimodality or trimodality therapy where appropriate. Recent advances have led to
alterations in radiotherapeutic technologies, the introduction of sequential (induction) systemic …

… Patients who had progressive disease or no response after one cycle of induction therapy
were formally represented to the head and neck tumor board, and their clinical response was …

… is the standard of care for inoperable locally advanced head and neck cancer, induction
chemotherapy is considered an alternative approach by head and neck oncologists worldwide. …

… Head and neck cancers comprise a heterogenous group of cancers that require a … in
head and neck cancer. Cancers of nasopharynx and salivary glands were excluded. …

… , and convenient therapies for inoperable Head and Neck cancer has led researchers to …
either induction or concurrent with radiation have emerged as a viable alternative. …

… )(PF) has been used as standard induction therapy; however, poor patient survival has …
induction therapy. The results of six phase II studies of docetaxel–PF regimens (TPF) as induction …

… For non-resectable LAHNSCC, the clinical interest of induction … With the approval of
immunotherapy and targeted therapy for … new strategies for LAHNSCC induction therapy, which …

… non-resectable head and neck cancer with radiotherapy and … modality regimens in this
situation induce higher rates of acute … The efficacy of low-level laser therapy in the management of …

… effective as induction therapy in previously untreated squamous cell head and neck cancer.
… This induction chemotherapy increases the probability of local control in patients presenting …

… Institute (Boston, MA), who have conducted almost a decade of research using combinations
of the docetaxel, cisplatin, and 5-fluorouracil regimen as induction therapy, with or without …